Lam Research Corporation — LRCX
| Close Price | Market Cap | P/E Ratio | Forward P/E Ratio | Implied Growth* | Implied Forward Growth* | Dividend | P/B Ratio |
|---|---|---|---|---|---|---|---|
| $208.79 | $263.29B | 46.2 | 36.3 | 20.7% | 17.9% | $1.04 0.5% | 25.8 |
Latest Headlines
- · ASML's Installed Base Management Business Picks Up: What's Driving it?
- · Will LRCX's China Revenue Drop Below 30% Hurt 2026 Growth Outlook?
- · See How Bullish Inflows Boost Lam Research
- · Lam Research (LRCX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- · The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Lam Research and Ampco-Pittsburgh
- · AMAT's Flash Memory Sales Nearly Double in FY25: What's Ahead?
Revenue & Net Income
| Date | Revenue | Net Income | EPS | Revenue Change | Net Income Change | EPS Change | |
|---|---|---|---|---|---|---|---|
| 0 | 2020-06-30 | $10.0B | $2.3B | $15.55 | N/A | N/A | N/A |
| 1 | 2021-06-30 | $14.6B | $3.9B | $27.22 | 45.6% | 73.6% | 75.0% |
| 2 | 2022-06-30 | $17.2B | $4.6B | $32.92 | 17.8% | 17.8% | 20.9% |
| 3 | 2023-06-30 | $17.4B | $4.5B | $33.30 | 1.2% | -2.0% | 1.2% |
| 4 | 2024-06-30 | $14.9B | $3.8B | $33.30 | -14.5% | -15.1% | 0.0% |
| 5 | TTM 2025-03-31 | $17.1B | $4.7B | $3.59 | 15.0% | 21.7% | -89.2% |
| 6 | Average | 13.0% | 19.2% | 1.6% |
EPS
Forecasts
Y/Y % Change
LRCX Year-over-Year Growth
| 2020 | 2021 | 2022 | 2023 | 2024 | 2026 | 2027 | Average | |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth (%) | 45.6% | 17.8% | 1.2% | -14.5% | 41.2% | 12.5% | 17.3% | |
| Revenue Analysts (#) | 0 | 0 | 0 | 0 | 0 | 7 | 7 | |
| EPS Growth (%) | 73.6% | 17.8% | -2.0% | -15.1% | 58.1% | 15.2% | 24.6% | |
| EPS Analysts (#) | 0 | 0 | 0 | 0 | 0 | 9 | 9 |
Expenses
| Year | Revenue ($) | Cost of Revenue ($) | R&D ($) | SG&A ($) | Facilities / D&A ($) |
|---|---|---|---|---|---|
| 2021 | $14.6B | $7.5B | $1.5B | $829.9M | $307.2M |
| 2022 | $17.2B | $9.0B | $1.6B | $885.7M | $333.7M |
| 2023 | $17.4B | $9.3B | $1.7B | $832.8M | $342.4M |
| 2024 | $14.9B | $7.5B | $1.9B | $868.2M | $359.7M |
| 2025 | $18.4B | $9.1B | $2.1B | $981.7M | $386.3M |
| TTM | $19.6B | $9.5B | $2.2B | $1.0B | $393.6M |
| Year | Revenue Change (%) | Cost of Revenue Change (%) | R&D Change (%) | SG&A Change (%) | Facilities / D&A Change (%) |
|---|---|---|---|---|---|
| 2022 | 17.78 | 20.07 | 7.42 | 6.73 | 8.66 |
| 2023 | 1.17 | 3.19 | 7.66 | -5.98 | 2.60 |
| 2024 | -14.48 | -19.51 | 10.15 | 4.26 | 5.04 |
| 2025 | 23.68 | 21.05 | 10.19 | 13.07 | 7.39 |
| TTM | 6.27 | 5.14 | 3.87 | 3.69 | 1.90 |
No unmapped expenses.
Balance Sheet
| Metric | Value | |
|---|---|---|
| 0 | Total Assets | $21,345M |
| 1 | Cash | $6,391M |
| 2 | Total Liabilities | $11,484M |
| 3 | Total Debt | $4,485M |
| 4 | Total Equity | $9,862M |
| 5 | Debt to Equity Ratio | 0.45 |
EPS & Dividend
Valuation
| Share Price | Treasury Yield | Estimates | Fair Value (P/E) | Fair Value (P/S) | Current P/S | Current P/E |
|---|---|---|---|---|---|---|
| $208.79 | 4.1% | Nicks Growth: 12% Nick's Expected Margin: 25% FINVIZ Growth: 17% |
Nicks: 21 Finviz: 34 |
Nick's: 5.328 | 13.4 | 46.2 |
| Basis | Year | Nicks Valuation | Nicks vs Share Price | Finviz Valuation | Finviz vs Share Price |
|---|---|---|---|---|---|
| $4.52 EPS | TTM | $96.33 | -53.9% | $151.68 | -27.4% |
| $4.80 EPS | 2026 | $102.29 | -51.0% | $161.07 | -22.9% |
| $5.53 EPS | 2027 | $117.85 | -43.6% | $185.57 | -11.1% |
Implied Growth
| Average | Median | Std Dev | Current | Percentile | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | |
| Timeframe | ||||||||||
| 1 Year | 16.01% | 15.37% | 16.09% | 15.71% | 1.99% | 2.08% | 21.01% | 18.23% | 98.0% | 92.7% |
| 3 Years | 16.01% | 15.37% | 16.09% | 15.71% | 1.99% | 2.08% | 21.01% | 18.23% | 98.0% | 92.7% |
| 5 Years | 16.01% | 15.37% | 16.09% | 15.71% | 1.99% | 2.08% | 21.01% | 18.23% | 98.0% | 92.7% |
| 10 Years | 16.01% | 15.37% | 16.09% | 15.71% | 1.99% | 2.08% | 21.01% | 18.23% | 98.0% | 92.7% |